Loading...
Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer
The anti-angiogenic agent bevacizumab has been approved for the treatment of non-small cell lung cancer, although the survival benefit associated with this agent is marginal, and toxicities and cost are substantial. A recent screen for selective inhibitors of endothelial cell proliferation identifie...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3206167/ https://ncbi.nlm.nih.gov/pubmed/21896639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-0691 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|